Admission Date:  [**2114-4-12**]     Discharge Date:  [**2114-4-19**]   Service:  [**Company 191**] MEDICI  HISTORY OF PRESENT ILLNESS:   This is a 79 year old woman with a history of atrial fibrillation with rapid ventricular rate status post pharmacologic conversion and status post pacemaker for tachy-brady syndrome with congestive heart failure, diastolic dysfunction, and poorly controlled hypertension, who presented with shortness of breath.
She reports good compliance with her home anti-hypertensives, but does not measure her blood pressures.
She says her diabetes mellitus is borderline diabetes mellitus but not on any medications nor does she check fingersticks at home.
She received a dose of Lopressor and Diltiazem in the Emergency Room with good response.
Also, she received 20 of intravenous Lasix, Nitroglycerin, digoxin and then had a CT scan of her chest done to evaluate for shortness of breath.
Coronary artery disease status post an myocardial infarction.
Recent echocardiogram in [**Month (only) **] showed an ejection fraction of 60% with mild to moderate mitral regurgitation and aortic regurgitation, prolonged E wave deceleration, impaired relaxation, mild pulmonary artery systolic hypertension.
Hydrochlorothiazide 25 mg p.o.
Lisinopril 40 mg p.o.
Amlodipine 10 mg p.o.
Aspirin 325 mg p.o.
Toprol XL 100 mg p.o.
SHORTNESS OF BREATH:  The patient was stable oxygen wise and was treated for pneumonia empirically with initially Ceftazidine and then switched over to Levofloxacin to complete a two week course; currently being discharged on day seven of two weeks.
They are prepared to continue with the treatment and arrangements have been made to set up initial visit on day of discharge with Dr. [**Last Name (STitle) **].
Eventually, Flagyl was added on for better anaerobic coverage and the patient is to complete a ten day course of this.
She continued to use her incentive spirometer and eventually was weaned off nasal cannula and saturating well even with ambulation.
She did not require oxygen for the last four days of her admission.
It was likely that the patient had a urinary source of her urinary tract infection but her E. coli was pan sensitive and the patient was continued on Levofloxacin for her urinary tract infection and her E. coli bacteremia.
She was continued on her home regimen of Diltiazem and Lopressor.
She was not on Coumadin secondary to fall risk and a question of compliance, and otherwise remained stable and asymptomatic.
CORONARY ARTERY DISEASE:  The patient was stable and continued on her metoprolol although her aspirin was held for procedures and can be restarted once her work-up for her lung cancer is completed.
DIABETES MELLITUS:  She was overall well controlled on a sliding scale, however, her fingersticks remained between 112 and 130 during the course of her stay with minimal sliding scale requirements.
She will continue at home off medications but advised to continue with diabetic diet.
HYPERTENSION:  She was continued on her Hydrochlorothiazide, Metoprolol and Diltiazem.
The patient aware of diagnosis although unsure if understands complete complications and associated issues associated with her diagnosis.
Hydrochlorothiazide 25 mg p.o.
Levofloxacin 250 mg p.o.
Flagyl 500 mg p.o.
Diltiazem 60 mg p.o.
Ipratropium MDI, two puffs inhaled four times a day.
Toprol XL 100 mg p.o.
